Group One Trading’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.77K Buy
370
+98
+36% +$2.44K ﹤0.01% 6397
2026
Q2
$6.6K Sell
272
-1,184
-81% -$20.2K ﹤0.01% 6609
2026
Q1
$22.6K Buy
+1,456
New +$24.1K ﹤0.01% 5877
2024
Q3
– Sell
-2,182
Closed -$49.4K – 7120
2024
Q2
$45.5K Buy
+2,182
New +$34K ﹤0.01% 4585
2022
Q3
– Sell
-100
Closed -$1.58K – 8008
2022
Q2
$1K Hold
100
– – ﹤0.01% 7589
2022
Q1
$1K Hold
100
– – ﹤0.01% 7845
2021
Q4
$3K Hold
100
– – ﹤0.01% 7798
2021
Q3
$3K Buy
+100
New +$3.09K ﹤0.01% 7873

Other funds holding NRIX

Group One Trading's NRIX Position: Q3 2026 in Review

Group One Trading increased its Nurix Therapeutics (NRIX) stake by 36% in Q3 2026, buying an estimated $2.44K and bringing the position to 370 shares worth $8.77K. The position accounts for ﹤0.01% of the portfolio, ranked #6397.

Group One Trading first reported a position in NRIX in Q3 2021 and has held it in 8 quarters since. The position peaked at $45.5K in Q2 2024. 233 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.

  • Group One Trading held 370 shares of Nurix Therapeutics worth $8.77K as of Q3 2026.
  • Group One Trading bought 98 Nurix Therapeutics shares in Q3 2026, an estimated $2.44K.
  • Nurix Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #6397 holding.
  • Group One Trading first reported a position in Nurix Therapeutics in Q3 2021 and has held it in 8 quarters since.
  • Group One Trading's Nurix Therapeutics position peaked at $45.5K in Q2 2024.
  • 233 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.